Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

SK Biopharmaceuticals revenues fell 70% in the first quarter

SK Biopharmaceuticals’ sales plummeted in the first quarter, compared to a year earlier, due to the base effect of a one-off income from a...

Merck KGaA expects adjusted profit to rise to 9% due to demand for laboratory products

Germany's Merck KGaA said it expects earnings growth of up to 9% this year, mainly driven by drugmakers' demand for its laboratory gear business,...

Roche’s 2nd cancer immunotherapy trial fails, shares down the most in a year

Development of a new cancer treatment pioneered by Roche was thrown into doubt on Wednesday when the immunotherapy drug failed to slow progression of...

Bavarian Nordic starts share buy-back program

Bavarian Nordic A/S May 9th announced the initiation of a new share buy-back program, under which the Company intends to buy back up to...

FDA lifts ban on LogicBio’s clinical trial on pediatric patients with methylmalonic acidemia

LogicBio Therapeutics, Inc., a clinical-stage company advancing a diversified pipeline of genetic medicines addressing rare disorders from infancy through adulthood, May 9th announced that...

Takeda Pharmaceutical expected fourth-quarter net income to decline

Takeda is expected to post a 92% drop in net profit from a year earlier to 15.96 billion yen ($122.3 million) for the quarter...
spot_img

Expert Articles

spot_img